About [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol
[4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol (PubChem CID 118006233) has the molecular formula C34H29ClF3N7O2
and a molecular weight of 660.10 g/mol. Its IUPAC name is [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol.
Molecular Properties
| Compound Name | [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol |
| PubChem CID | 118006233 |
| Molecular Formula | C34H29ClF3N7O2 |
| Molecular Weight | 660.10 g/mol |
| Exact Mass | 659.20 |
| IUPAC Name | [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol |
| SMILES | Cn1cncc1C(O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCOCC3)c(Cc3ccc(-n4cccn4)cc3)c(Cl)c2c1 |
| InChI | InChI=1S/C34H29ClF3N7O2/c1-43-21-39-20-30(43)33(46,24-6-10-29(40-19-24)34(36,37)38)23-5-9-28-26(18-23)31(35)27(32(42-28)44-13-15-47-16-14-44)17-22-3-7-25(8-4-22)45-12-2-11-41-45/h2-12,18-21,46H,13-17H2,1H3 |
| InChIKey | GALLRUNKDAVIAD-UHFFFAOYSA-N |
| XLogP | 5.93 |
| TPSA | 94.12 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 660.10 |
| LogP ≤ 5 | 5.93 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Analyze [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol?
The IUPAC name of [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol (CID 118006233) is [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol.
What is the SMILES notation for [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol?
The canonical SMILES for [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol is Cn1cncc1C(O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCOCC3)c(Cc3ccc(-n4cccn4)cc3)c(Cl)c2c1.
What is the InChIKey of [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol?
The InChIKey is GALLRUNKDAVIAD-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H29ClF3N7O2/c1-43-21-39-20-30(43)33(46,24-6-10-29(40-19-24)34(36,37)38)23-5-9-28-26(18-23)31(35)27(32(42-28)44-13-15-47-16-14-44)17-22-3-7-25(8-4-22)45-12-2-11-41-45/h2-12,18-21,46H,13-17H2,1H3.
What are the key properties of [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol?
[4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol has a molecular weight of 660.10 g/mol, XLogP of 5.93, 7 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [4-chloro-2-morpholin-4-yl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-(3-methylimidazol-4-yl)-[6-(trifluoromethyl)-3-pyridinyl]methanol is sourced from PubChem (CID 118006233), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).